| 1 |
35279152 | Tumorigenic circulating tumor cells from xenograft mouse models of non-metastatic NSCLC patients reveal distinct single cell heterogeneity and drug responses. | 2022 Mar 12 |
3 |
| 2 |
34610216 | Possibility of paclitaxel to induce the stemness-related characteristics of prostate cancer cells. | 2021 Dec |
1 |
| 3 |
31655296 | Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses. | 2020 Feb |
1 |
| 4 |
32275943 | HMGB1 release promotes paclitaxel resistance in castration-resistant prostate cancer cells via activating c-Myc expression. | 2020 Aug |
8 |
| 5 |
32431514 | Tetrandrine Reverses Paclitaxel Resistance in Human Ovarian Cancer via Inducing Apoptosis, Cell Cycle Arrest Through β-Catenin Pathway. | 2020 |
3 |
| 6 |
32779438 | Overexpression of GATA5 Stimulates Paclitaxel to Inhibit Malignant Behaviors of Hepatocellular Carcinoma Cells. | 2020 Jul |
1 |
| 7 |
30359947 | MYC-Induced miR-203b-3p and miR-203a-3p Control Bcl-xL Expression and Paclitaxel Sensitivity in Tumor Cells. | 2019 Jan |
2 |
| 8 |
31164413 | The Sustained Induction of c-MYC Drives Nab-Paclitaxel Resistance in Primary Pancreatic Ductal Carcinoma Cells. | 2019 Sep |
1 |
| 9 |
31506466 | Pre-treatment with the CDK4/6 inhibitor palbociclib improves the efficacy of paclitaxel in TNBC cells. | 2019 Sep 10 |
1 |
| 10 |
28870680 | Correlation of MYC Gene and Protein Status With Breast Cancer Subtypes and Outcome of Patients Treated With Anthracycline-Based Adjuvant Chemotherapy. Pooled Analysis of 2 Hellenic Cooperative Group Phase III Trials. | 2018 Feb |
2 |
| 11 |
29434885 | Low-dose paclitaxel downregulates MYC proto-oncogene bHLH transcription factor expression in colorectal carcinoma cells. | 2018 Feb |
3 |
| 12 |
28817737 | Myc mediates cancer stem-like cells and EMT changes in triple negative breast cancers cells. | 2017 |
2 |
| 13 |
25708932 | C-MYC modulation induces responsiveness to paclitaxel in adrenocortical cancer cell lines. | 2015 May |
5 |
| 14 |
25835050 | c-Myc modulation: a key role in melanoma drug response. | 2015 |
1 |
| 15 |
25849888 | β-Catenin expression is regulated by an IRES-dependent mechanism and stimulated by paclitaxel in human ovarian cancer cells. | 2015 May 22 |
2 |
| 16 |
26175417 | MYC Is a Major Determinant of Mitotic Cell Fate. | 2015 Jul 13 |
1 |
| 17 |
26462028 | Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells. | 2015 Nov 10 |
1 |
| 18 |
26722421 | Amplification of chromosome 8q21-qter associated with the acquired paclitaxel resistance of nasopharyngeal carcinoma cells. | 2015 |
1 |
| 19 |
25546354 | Effects of suberoylanilide hydroxamic acid (SAHA) combined with paclitaxel (PTX) on paclitaxel-resistant ovarian cancer cells and insights into the underlying mechanisms. | 2014 |
1 |
| 20 |
21741827 | Association between c-myc amplification and pathological complete response to neoadjuvant chemotherapy in breast cancer. | 2011 Aug |
1 |
| 21 |
20717708 | Analysis of the protein expression changes during taxol-induced apoptosis under translation inhibition conditions. | 2010 Dec |
3 |
| 22 |
19421315 | MYC prevents apoptosis and enhances endoreduplication induced by paclitaxel. | 2009 |
4 |
| 23 |
17404030 | Effect of paclitaxel on intracellular localization of c-Myc and P-c-Myc in prostate carcinoma cell lines. | 2007 Jan |
10 |
| 24 |
17565738 | Camptothecin-induced apoptosis is enhanced by Myc and involves PKCdelta signaling. | 2007 Oct 15 |
1 |
| 25 |
16243823 | Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. | 2005 Oct 15 |
1 |
| 26 |
15294455 | Role of c-myc protein in hormone refractory prostate carcinoma: cellular response to paclitaxel. | 2004 Sep 1 |
6 |
| 27 |
14516787 | Multiple effects of paclitaxel are modulated by a high c-myc amplification level. | 2003 Oct 15 |
9 |
| 28 |
12435808 | c-Myc exerts a protective function through ornithine decarboxylase against cellular insults. | 2002 Dec |
1 |
| 29 |
10885610 | Opposite effects of antimicrotubule agents on c-myc oncogene expression depending on the cell lines used. | 2000 May |
2 |
| 30 |
9070886 | Pretreatment by tubulin agents decreases C-MYC induction in human colon carcinoma cell line HT29-D4. | 1997 Feb 24 |
3 |
| 31 |
8096557 | Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. | 1993 Apr |
1 |